New monitor aims to prevent dangerous side effects in type 1 diabetes treatment
NCT ID NCT07211802
First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 35 times
Summary
This study tests whether wearing a continuous ketone monitor alongside a continuous glucose monitor can reduce the risk of a serious side effect (high ketones) from the drug sotagliflozin in people with type 1 diabetes. About 52 adults will take two different doses of the drug while wearing the monitors. The goal is to make this treatment safer and more usable.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES (T1D) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
UCSD - Altman Clinical & Translational Research Institute
La Jolla, California, 92037, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.